Indian Army OINT ANTI-HAEMORRHOIDAL Topical Ointments & Gels Procurement 2026 - Department Of Military Affairs, India
Bid Publish Date
02-Sep-2026, 1:35 pm
Bid End Date
12-Sep-2026, 2:00 pm
Location
Progress
Tender Overview
The Indian Army, Department Of Military Affairs, invites bids for the supply of a broad portfolio of topical formulations, including HYDROCORTISONE ACETATE 5.58 MG, FRAMYCETIN 10 MG, HEPARIN 100 IU, ESCULOSIDE 10 MG, ETHYL AMINO BENZOATE 10 MG, BUTYL AMINO BENZOATE 10 MG, SILVER SULFADIAZINE 1%, STERILIC TUBE 25 G, ADAPALENE 0.1%, CLINDAMYCIN 1%, CLINDAMYCIN PHOSPHATE 1%, UREA CREAM 10-12% LACTIC ACID 5-10% (50 GM packs), CLOBETASOL, MOMETASONE 0.1% (10 GM), KETOCONAZOLE 2% 30G, DEBRADACE, HALOBETASOL OINT, BENZOCAINE TOPICAL ANESTHETIC. Scope: only supply of goods; 11 items covered; procurement location unspecified; indicative value not disclosed; project requires adherence to the purchaser’s delivery and variation rules. An option clause allows quantity variation up to 25% at contracted rates; extended delivery time calculations apply, with a minimum of 30 days.
Technical Specifications & Requirements
- Product categories span anti-hemorrhoidal and dermatological topical medicines and ointments/creams in tube or gel form, including combination formulations.
- No explicit technical standards or IS/ISO specifications published in the available data.
- BOQ lists 11 items; detailed unit quantities are not disclosed in the summary data.
- Scope requires “Only supply of Goods”; bidders must price all cost components for the bid price.
- Delivery period mechanics rely on the last date of the original delivery order; option-driven time extensions are computed by (increased quantity ÷ original quantity) × original period, minimum 30 days.
- Brand/OEM or formulation-specific requirements are not stated; bidders should assume standard pharmaceutical packaging compliance.
Terms, Conditions & Eligibility
- EM D/financial guarantees: Not disclosed in the provided data; bidders should prepare standard security as per organization policy.
- Delivery terms: Delivery period commences from the last date of the original delivery order; option clause allows ±25% quantity variation during and after contract.
- Payment terms: Not specified in the extract; expected to follow government procurement norms for supply-only tenders, to be confirmed during bid submission.
- Documents required: GST registration, PAN, experience certificates, financial statements, EMD/Security deposit, OEM authorizations, and technical/compliance certificates as applicable; ensure readiness for submission.
- Eligibility: Supply experience in pharmaceutical or topical formulations is implied; verify any organization-specific prerequisites during bid prep.
- Penalties: Not specified here; confirm LD provisions and performance bonds in the final terms.
Key Specifications
-
- Product/service names: HYDROCORTISONE ACETATE 5.58 MG, FRAMYCETIN 10 MG, HEPARIN 100 IU, ESCULOSIDE 10 MG, ETHYL AMINO BENZOATE 10 MG, BUTYL AMINO BENZOATE 10 MG, SILVER SULFADIAZINE 1%, ADAPALENE 0.1%, CLINDAMYCIN 1%, CLINDAMYCIN PHOSPHATE 1%, UREA CREAM 10-12% with LACTIC ACID 5-10%, CLOBETASOL, MOMETASONE 0.1%, KETOCONAZOLE 2% (30 G), DEBRADACE, HALOBETASOL OINT, BENZOCAINE TOPICAL ANESTHETIC
-
- Quantities: 11 items, specific unit quantities not disclosed in the data
-
- Estimated value/EMD: Not disclosed in the tender excerpt
-
- Standards/Quality: No explicit standards published in the provided data
-
- Delivery and packaging: Sterile tubes (25 G) and tube/gel formats as listed
-
- Branding: No clear brand/OEM specification stated; assume pharmaceutical-grade packaging
-
- Acceptance: Supply-only scope; no installation or service components mentioned
Terms & Conditions
-
Key Term 1: Quantity variation up to 25% allowed at contract time
-
Key Term 2: Delivery time extended based on extra quantity with minimum 30 days
-
Key Term 3: Delivery starts from the last date of the original delivery order
Important Clauses
Delivery Schedule
Delivery period commences from the last date of the original delivery order; additional time for increased quantity is calculated as (Increased quantity ÷ Original quantity) × Original delivery period, with a 30-day minimum.
Payment Terms
Not specified in the excerpt; payment terms to be confirmed during bid submission; bidders should anticipate standard government supply terms for goods only.
Penalties/Liquidated Damages
No explicit penalty clause provided in the extract; verify LD provisions during final bid documentation.
Bidder Eligibility
-
Experience in supplying topical pharmaceutical products or related medical formulations
-
Compliant GST registration and financial stability demonstrated by recent financial statements
-
Ability to meet delivery deadlines and honor quantity variation terms up to 25%
Tender Data
Bid Details
Quantity
1575
Category
OINT ANTI HAEMORRHOIDAL CONTAINING HYDROCORTISONE ACETATE 5 point 58 MG FRAMYCETIN 10 MG HEPARIN 100 IU ESCULOSIDE 10 MG ETHYL AMINO BENZOATE 10 MG BUTYL AMINO BENZOATE 10 MG
Bid Type
Two Packet Bid
Bid Validity
90 (Days)
Bid Type
Service
Evaluation
Item wise evaluation
Inspection Required
No
Tech Clarification Time
2 Days
Preference & Exemptions
EMD Required
No
MII Purchase Preference
No
MSE Purchase Preference
Yes
MSE Preference Band
L1+15%
MSE Exemption/Relaxation
Yes
Startup Exemption/Relaxation
No
Bid Splitting Applied
No
Requirements
Past Performance
20 %
Arbitration Clause
No
Mediation Clause
No
Additional Tender Data
Commercial Details
Tender Category
Goods
Bid To RA
No
Bid To RA Enabled
No
Item Category
OINT ANTI HAEMORRHOIDAL CONTAINING HYDROCORTISONE ACETATE 5 point 58 MG FRAMYCETIN 10 MG HEPARIN 100 IU ESCULOSIDE 10 MG ETHYL AMINO BENZOATE 10 MG BUTYL AMINO BENZOATE 10 MG , OINT SILVER SULFADIAZINE 1 percent STERILIC TUBE OF 25 G , OINT ADAPALENE 0 point 1percent CLINDAMYCIN 1 percent , OINT CLINDAMYCIN PHOSPHATE 1 percent TOPICAL GEL TUBE OF 10 GM , UREA CREAM UREA 10 TO 12 LACTIC ACID 5 TO 10 IN PACK OF 50 GM , OINT CLOBETASOL GM , OINT MOMETASONE 0 point 1 TUBE OF 10 GM , OINT KETOCONAZOLE 2 percent 30 G TUBE , Oint Debradace , HALOBETASOL OINT , BENZOCAINE TOPICAL ANAESTHETIC
Delivery Details
Max Delivery Days
21
Delivery Locations
1
Delivery Cities
HYDERABAD
Delivery Locations
| Consignee | Address | City | State | Pincode | Quantity | Delivery Days | Additional Requirement |
|---|---|---|---|---|---|---|---|
| - | HYDERABAD | HYDERABAD | - | - | 160 | 21 | - |
Authority Records
BID & GeM Expert Consultancy
End-to-end support — bid preparation, GeM registration, document filing & compliance by industry experts.
Free consultation · 24h response
Documents 4
GeM-Bidding-9836630.pdf
Main Document
BOQ Document
BOQ
BOQ Document
BOQ
GEM General Terms and Conditions Document
GEM_GENERAL_TERMS_AND_CONDITIONS
Bill of Quantities (BOQ)
11 Items Sign in to view GEM price trends Sign in for GEM prices
OINT ANTI HAEMORRHOIDAL CONTAINING HYDROCORTISONE ACETATE 5 point 58 MG FRAMYCETIN 10 MG HEPARIN 100 IU ESCULOSIDE 10 MG ETHYL AMINO BENZOATE 10 MG BUTYL AMINO BENZOATE 10 MG
oint
OINT SILVER SULFADIAZINE 1 percent STERILIC TUBE OF 25 G
oint
OINT ADAPALENE 0 point 1percent CLINDAMYCIN 1 percent
oint
OINT CLINDAMYCIN PHOSPHATE 1 percent TOPICAL GEL TUBE OF 10 GM
oint
UREA CREAM UREA 10 TO 12 LACTIC ACID 5 TO 10 IN PACK OF 50 GM
cream
OINT CLOBETASOL GM
oint
OINT MOMETASONE 0 point 1 TUBE OF 10 GM
oint
OINT KETOCONAZOLE 2 percent 30 G TUBE
oint
Oint Debradace
oint
HALOBETASOL OINT
oint
BENZOCAINE TOPICAL ANAESTHETIC
oint
| Item # | Title | Description | Quantity | Unit | Consignee | Delivery (Days) | Price Trends |
|---|---|---|---|---|---|---|---|
| 1 | OINT ANTI HAEMORRHOIDAL CONTAINING HYDROCORTISONE ACETATE 5 point 58 MG FRAMYCETIN 10 MG HEPARIN 100 IU ESCULOSIDE 10 MG ETHYL AMINO BENZOATE 10 MG BUTYL AMINO BENZOATE 10 MG | oint | 160 | no | ms18473f | 21 | |
| 2 | OINT SILVER SULFADIAZINE 1 percent STERILIC TUBE OF 25 G | oint | 100 | tube | ms18473f | 21 | |
| 3 | OINT ADAPALENE 0 point 1percent CLINDAMYCIN 1 percent | oint | 90 | tube | ms18473f | 21 | |
| 4 | OINT CLINDAMYCIN PHOSPHATE 1 percent TOPICAL GEL TUBE OF 10 GM | oint | 130 | tube | ms18473f | 21 | |
| 5 | UREA CREAM UREA 10 TO 12 LACTIC ACID 5 TO 10 IN PACK OF 50 GM | cream | 300 | tube | ms18473f | 21 | |
| 6 | OINT CLOBETASOL GM | oint | 210 | tube | ms18473f | 21 | |
| 7 | OINT MOMETASONE 0 point 1 TUBE OF 10 GM | oint | 260 | tube | ms18473f | 21 | |
| 8 | OINT KETOCONAZOLE 2 percent 30 G TUBE | oint | 160 | tube | ms18473f | 21 | |
| 9 | Oint Debradace | oint | 35 | tube | ms18473f | 21 | |
| 10 | HALOBETASOL OINT | oint | 100 | no | ms18473f | 21 | |
| 11 | BENZOCAINE TOPICAL ANAESTHETIC | oint | 30 | bott | ms18473f | 21 |
Categories
8
🤖 AI-Powered Bidder Prediction
Discover companies most likely to bid on this tender
Required Documents
GST registration certificate
PAN card
Experience certificates for prior supply of topical pharmaceutical products
Financial statements (last 2-3 years) demonstrating liquidity
EMD/ security deposit documentary evidence (if required by contract terms)
Technical bid documents showing product specifications and compliance
OEM authorization letters or manufacturer credentials for each item
Any quality/compliance certificates relevant to topical formulations
Frequently Asked Questions
How to bid for Indian Army topical medicines tender 2026 in India
Bidders should ensure GST registration, PAN, experience certificates, and financial statements are ready. Prepare OEM authorizations and technical compliance documents for each listed item. Bind bids under the ‘Only supply of Goods’ scope, and be prepared to meet the 25% quantity variation clause and delivery-time mechanism described.
What documents are required for Army topical formulation procurement 2026
Submit GST registration, PAN, experience certificates of similar supply, last 3 years financial statements, EMD documentation if applicable, OEM authorizations, and technical bid with formulation names, packaging, and batch details. Ensure packaging adheres to pharmaceutical standards and includes sterilization details where relevant.
What are the key product specifications for anti-hemorrhoidal ointments in this tender
The tender lists items including hydrocortisone acetate, framycetin, heparin, esculoside, benzocaine, adapalene, clindamycin and related creams/gels. No explicit IS/ISO standard numbers are published in the excerpt; bidders should supply pharmaceutical-grade formulations meeting general quality norms and packaging integrity.
When is delivery time adjusted for quantity changes in Army tender 2026
Delivery time adjusts using the formula: (Increased quantity ÷ Original quantity) × Original delivery period, with a minimum of 30 days. If original delivery is shorter, the minimum time equals the original, and extensions may apply during the extended delivery period.
What are the EMD and payment terms for the Army goods tender 2026
EMD details are not disclosed in the provided data; bidders should prepare as per standard government practice. Payment terms are not specified; expect supply-only terms with milestones to be clarified during bid submission and contract finalization.
How to verify OEM authorizations for topical formulations in Army tender
Obtain clear OEM authorization letters for each listed item, showing manufacturing rights for hydrocortisone, framycetin, heparin, clindamycin, ketoconazole, halobetasol, and related products. Attach these with the technical bid and confirm packaging, batch traceability, and shelf-life data for government review.
What qualifications are needed to participate in the Army pharmacological tender
Participants should demonstrate prior supply of topical pharmaceutical products, furnish GST/PAN and financial stability, provide experience certificates, and include OEM authorizations. Ensure compliance with general pharmaceutical packaging norms and readiness to meet quantity variation up to 25%.
What is the scope of supply for the Army medical formulations tender 2026
The scope is strictly 'Only supply of Goods' for 11 listed items in tube or gel form (e.g., hydrocortisone acetate, framycetin, halobetasol, ketoconazole). No installation or service work is required; ensure all packaging and labels meet regulatory standards for government procurement.